Literature DB >> 29232185

18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.

Xifu Wang1, Zhanliang Su1, Tianchu Lyu1, Matteo Figini1, Daniel Procissi1, Junjie Shangguan1, Chong Sun1, Bin Wang1, Na Shang1, Shanzhi Gu1, Quanhong Ma1, Andrew C Gordon1, Kai Lin1, Jian Wang1, Robert J Lewandowski1, Riad Salem1, Vahid Yaghmai1, Andrew C Larson1, Zhuoli Zhang1.   

Abstract

Purpose To test the hypothesis that biomarkers of fluorine 18 (18F) fluorodeoxyglucose (FDG) positron emission tomography (PET) can be used for the early detection of therapeutic response to irreversible electroporation (IRE) of liver tumor in a rodent liver tumor model. Materials and Methods The institutional animal care and use committee approved this study. Rats were inoculated with McA-RH7777 liver tumor cells in the left median and left lateral lobes. Tumors were allowed to grow for 7 days to reach a size typically at least 5 mm in longest diameter, as verified with magnetic resonance (MR) imaging. IRE electrodes were inserted, and eight 100-μsec, 2000-V pulses were applied to ablate the tumor tissue in the left median lobe. Tumor in the left lateral lobe served as a control in each animal. PET/computed tomography (CT) and MR imaging measurements were performed at baseline and 3 days after IRE for each animal. Additional MR imaging measurements were obtained 14 days after IRE. After 14-day follow-up MR imaging, rats were euthanized and tumors harvested for hematoxylin-eosin, CD34, and caspase-3 staining. Change in the maximum standardized uptake value (ΔSUVmax) was calculated 3 days after IRE. The maximum lesion diameter change (ΔDmax) was measured 14 days after IRE by using axial T2-weighted imaging. ΔSUVmax and ΔDmax were compared. The apoptosis index was calculated by using caspase-3-stained slices of apoptotic tumor cells. Pearson correlation coefficients were calculated to assess the relationship between ΔSUVmax at 3 days and ΔDmax (or apoptosis index) at 14 days after IRE treatment. Results ΔSUVmax, ΔDmax, and apoptosis index significantly differed between treated and untreated tumors (P < .001 for all). In treated tumors, there was a strong correlation between ΔSUVmax 3 days after IRE and ΔDmax 14 days after IRE (R = 0.66, P = .01) and between ΔSUVmax 3 days after IRE and apoptosis index 14 days after IRE (R = 0.57, P = .04). Conclusion 18F-FDG PET imaging biomarkers can be used for the early detection of therapeutic response to IRE treatment of liver tumors in a rodent model. © RSNA, 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29232185      PMCID: PMC5881638          DOI: 10.1148/radiol.2017170920

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  US findings after irreversible electroporation ablation: radiologic-pathologic correlation.

Authors:  Liat Appelbaum; Eliel Ben-David; Jacob Sosna; Yizhak Nissenbaum; S Nahum Goldberg
Journal:  Radiology       Date:  2011-11-21       Impact factor: 11.105

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

3.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

4.  Ultrasound and Contrast-Enhanced Ultrasound for Evaluation of Irreversible Electroporation Ablation: In Vivo Proof of Concept in Normal Porcine Liver.

Authors:  Man-Xia Lin; Ming Kuang; Ming Xu; Bo-Wen Zhuang; Wen-Shuo Tian; Jie-Yi Ye; Xiao-Hua Xie; Xiao-Yan Xie
Journal:  Ultrasound Med Biol       Date:  2016-08-18       Impact factor: 2.998

5.  Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT.

Authors:  C Bartolozzi; R Lencioni; D Caramella; A Palla; A M Bassi; G Di Candio
Journal:  Acta Radiol       Date:  1996-01       Impact factor: 1.990

6.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Authors:  Yue Zhang; Sarah B White; Jodi R Nicolai; Zhuoli Zhang; Derek L West; Dong-Hyun Kim; A Lee Goodwin; Frank H Miller; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2014-02-18       Impact factor: 11.105

Review 7.  Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.

Authors:  Riccardo Lencioni; Thierry de Baere; Robert C Martin; Charles W Nutting; Govindarajan Narayanan
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

8.  Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.

Authors:  Vineet Pant; Ishita B Sen; Arvinder S Soin
Journal:  Nucl Med Commun       Date:  2013-08       Impact factor: 1.690

9.  Detection of hypervascular hepatocellular carcinoma by using spiral volumetric CT: comparison of US and MR imaging.

Authors:  K Ueda; K Kitagawa; M Kadoya; O Matsui; T Takashima; T Yamahana
Journal:  Abdom Imaging       Date:  1995 Nov-Dec

10.  MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.

Authors:  Laurien G P H Vroomen; Hester J Scheffer; Marleen C A M Melenhorst; Marcus C de Jong; Janneke E van den Bergh; Cornelis van Kuijk; Foke van Delft; Geert Kazemier; Martijn R Meijerink
Journal:  Eur Radiol       Date:  2016-09-22       Impact factor: 5.315

View more
  4 in total

1.  Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

Authors:  Aydin Eresen; Kang Zhou; Chong Sun; Junjie Shangguan; Bin Wang; Liang Pan; Su Hu; Yongsheng Pang; Zigeng Zhang; Robert Minh Nhat Tran; Ajeet Pal Bhatia; Farouk Nouizi; Nadine Abi-Jaoudeh; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 2.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  An overview of the irreversible electroporation for the treatment of liver metastases: When to use it.

Authors:  Maria Paola Belfiore; Marco De Chiara; Alfonso Reginelli; Alfredo Clemente; Fabrizio Urraro; Roberto Grassi; Giuseppe Belfiore; Salvatore Cappabianca
Journal:  Front Oncol       Date:  2022-09-01       Impact factor: 5.738

Review 4.  Recent progress in pulsed electric field ablation for liver cancer.

Authors:  Zhen-Guo Liu; Xin-Hua Chen; Zu-Jiang Yu; Jun Lv; Zhi-Gang Ren
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.